 | Nektar Therapeutics | |||
| NCM : NKTR || Location: United States | ||||
$1.36+0.03 (+2.65%) |
0.05 M | 1.32 - 1.36 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 3.113 M |
| March 28, 2024 | 2.359 M |
| March 15, 2024 | 2.515 M |
| Feb. 29, 2024 | 2.006 M |
| Feb. 15, 2024 | 2.454 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.22 | -0.22 | -1.57% |
| 09/30/2023 | -0.20 | -0.24 | -17.99% |
| 06/30/2023 | -0.29 | -0.27 | 6.77% |
| 03/31/2023 | -0.26 | -0.32 | -24.22% |
| 12/31/2022 | -0.46 | -0.32 | 30.65% |
NKTR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 183.618M | Shares Float | 163.108M |
| Short Float | 3.113M | Market Cap | 242.38M |
| Institution ownership | 66.80% | Insider ownership | 0.822% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.45 | Forward EPS | -0.71 |